Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
ChatGPT & cardiology: A close look at the potential of chatbots | Medtronic’s extravascular ICD gains key approval
Tuesday, February 21, 2023
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Today's News and Trends

ChatGPT and cardiology: A close look at the strengths and weaknesses of AI chatbots

Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. 

READ MORE >
A team of cardiologists from Cleveland Clinic and Stanford University recently tested ChatGPT, the popular artificial intelligence (AI) model, to see if it could accurately answer questions about preventive cardiology and cardiovascular disease. The model performed well, only missing a handful of questions, and the researchers concluded that ChatGPT showed considerable potential. Cleveland Clinic cardiologist Ashish Sarraju, MD, was the lead author of that study. #ChartGPT
Share on Twitter Share on Facebook Share on Linkedin

ChatGPT and cardiology: A close look at the strengths and weaknesses of AI chatbots

Share on Twitter Share on Facebook Share on Linkedin
A team of cardiologists from Cleveland Clinic and Stanford University recently tested ChatGPT, the popular artificial intelligence (AI) model, to see if it could accurately answer questions about preventive cardiology and cardiovascular disease. The model performed well, only missing a handful of questions, and the researchers concluded that ChatGPT showed considerable potential. Cleveland Clinic cardiologist Ashish Sarraju, MD, was the lead author of that study. #ChartGPT
Ashish Sarraju, MD, a cardiologist with Cleveland Clinic, discussed his recent research on ChatGPT, its potential to change patient care and more. 
READ MORE >

Medtronic’s new extravascular ICD gains key approval

Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 

READ MORE >
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Share on Twitter Share on Facebook Share on Linkedin

Medtronic’s new extravascular ICD gains key approval

Share on Twitter Share on Facebook Share on Linkedin
Medtronic shared some good news with attendees at ESC Congress 2022 in Barcelona, the annual meeting of the European Society of Cardiology, noting that its Extravascular Implantable Cardioverter Defibrillator (EV ICD) system met its safety endpoints in a global clinical trial. Medtronic EV ICD clinical trial safety endpoints ESC Congress 2022 #ESC #ESC2022 #ESC22
Unlike other ICDs, the lead for this new-look device is placed under the patient's breastbone, outside of their heart and veins. 
READ MORE >

Featured Articles

ACC urges all interventional cardiologists to use intravascular imaging during PCI

New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 

READ MORE >
The ACC released a new guideline asking interventional cardiologists to use intravascular imaging to improve outcomes in percutaneous coronary intervention (PCI). Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 
Share on Twitter Share on Facebook Share on Linkedin

ACC urges all interventional cardiologists to use intravascular imaging during PCI

Share on Twitter Share on Facebook Share on Linkedin
The ACC released a new guideline asking interventional cardiologists to use intravascular imaging to improve outcomes in percutaneous coronary intervention (PCI). Intravascular ultrasound (IVUS) is a catheter-based imaging technology that allows physicians to visualize blood vessels from the inside out. Image courtesy of Philips. 
New recommendations from the American College of Cardiology detail how intravascular imaging can help clinicians before, during and after PCI procedures. 
READ MORE >

AHA President Michelle Albert on addressing health equity issues in cardiology

American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.

READ MORE >
AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.
Share on Twitter Share on Facebook Share on Linkedin

AHA President Michelle Albert on addressing health equity issues in cardiology

Share on Twitter Share on Facebook Share on Linkedin
AHA President Michelle Albert explains what can be done to boost healthcare equity and diversity in cardiology.
American Heart Association President Michelle Albert, MD, talked to us about about how to address health inequities in cardiology departments.
READ MORE >

Vericiguat consistently linked to positive outcomes, limited side effects among heart failure patients

Reviewing data from several studies, researchers wrote that vericiguat (Verquvo) could potentially "become a breakthrough in the treatment of heart failure." 

READ MORE >
family visits with doctor
Share on Twitter Share on Facebook Share on Linkedin

Vericiguat consistently linked to positive outcomes, limited side effects among heart failure patients

Share on Twitter Share on Facebook Share on Linkedin
family visits with doctor
Reviewing data from several studies, researchers wrote that vericiguat (Verquvo) could potentially "become a breakthrough in the treatment of heart failure." 
READ MORE >

In Case You Missed It

New Jersey hospital performs 4,000th TAVR procedure

Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States. 

READ MORE >
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Share on Twitter Share on Facebook Share on Linkedin

New Jersey hospital performs 4,000th TAVR procedure

Share on Twitter Share on Facebook Share on Linkedin
Balloon expansion deployment of an Edwards Lifesciences Sapien 3 transcatheter aortic valve replacement (TAVR) device.
Morristown Medical Center first started performing TAVR procedures in 2011 and is now home to one of the largest TAVR programs in the United States. 
READ MORE >

Where renal denervation stands for the treatment of drug-resistant hypertension

Ajay Kirtane, MD, director of the cardiac catheterization laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center, explained the most recent clinical trial data on this topic. 

READ MORE >
Ajay J. Kirtane, MD, director of the cardiac catheterization laboratories and professor of medicine at NewYork-Presbyterian/Columbia University Irving Medical Center, explains the current trial data on catheter renal denervation to treat drug-resistant hypertension at AHA 2022.
Share on Twitter Share on Facebook Share on Linkedin

Where renal denervation stands for the treatment of drug-resistant hypertension

Share on Twitter Share on Facebook Share on Linkedin
Ajay J. Kirtane, MD, director of the cardiac catheterization laboratories and professor of medicine at NewYork-Presbyterian/Columbia University Irving Medical Center, explains the current trial data on catheter renal denervation to treat drug-resistant hypertension at AHA 2022.
Ajay Kirtane, MD, director of the cardiac catheterization laboratories at NewYork-Presbyterian/Columbia University Irving Medical Center, explained the most recent clinical trial data on this topic. 
READ MORE >

In Other News

Expert left 'astounded' by gadolinium discovery

New data out of the University of New Mexico suggest that the imaging agent’s physiologic reach may exceed what was previously believed.

READ MORE >
gadolinium, GBCAs
Share on Twitter Share on Facebook Share on Linkedin

Expert left 'astounded' by gadolinium discovery

Share on Twitter Share on Facebook Share on Linkedin
gadolinium, GBCAs
New data out of the University of New Mexico suggest that the imaging agent’s physiologic reach may exceed what was previously believed.
READ MORE >

Older women with breast cancer can safely forego radiation therapy

New data suggest that it may not be necessary for women older than 65 with hormone receptor-positive breast cancer to undergo radiotherapy after breast-conserving surgery and hormone therapy, as it does not impact death rates or metastasis risk.

READ MORE >
womanconsultation.jpg
Share on Twitter Share on Facebook Share on Linkedin

Older women with breast cancer can safely forego radiation therapy

Share on Twitter Share on Facebook Share on Linkedin
womanconsultation.jpg
New data suggest that it may not be necessary for women older than 65 with hormone receptor-positive breast cancer to undergo radiotherapy after breast-conserving surgery and hormone therapy, as it does not impact death rates or metastasis risk.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

Week in Review: When the risk of death from COVID-19 skyrockets | Burnout in cardiology | Hypertension & COVID-19
Stroke surgeons share COVID-19 warning | Cardiologist-led COVID-19 research | E-cigarettes & smoking
Hypertension | April 2020
Month in Review: 10 Trending Stories from March
Acute Coronary Syndrome | March 2020
Risk of death jumps when COVID-19 patients have CVD & myocardial injury | Stories from the front lines of the pandemic
Week in Review: Cardiac injury & COVID-19 | The pandemic's impact on healthcare workers | How statins can reduce HF risk

Pagination

    • First page « First
    • Previous page ‹‹
    • Page …347
    • Page 348
    • Page 349
    • Page 350
    • Current page 351
    • Page 352
    • Page 353
    • Page 354
    • Page 355
    • Next page ››
    • Last page Last »
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
 
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
 
Design by Adaptive Theme